|
Report Date : |
09.01.2013 |
IDENTIFICATION DETAILS
|
Name : |
AMOUN PHARMACEUTICALS CO SAE |
|
|
|
|
Registered Office : |
Block No. 51031 Cairo-Ismalia Road, Km-76 1st First
Industrial Zone, El Obour City PO Box
5 Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Year of Incorporation : |
1989 |
|
|
|
|
Com. Reg. No.: |
1677, El Obour |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Production of various chemicals. |
|
|
|
|
No. of Employees : |
2,800 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EGYPT - ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate GDP growth. Despite the relatively high levels of economic growth in recent years, living conditions for the average Egyptian remained poor and contributed to public discontent. After unrest erupted in January 2011, the Egyptian Government drastically increased social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction are among the hardest hit sectors of the Egyptian economy, and economic growth is likely to remain slow at least through 2012. The government is utilizing foreign exchange reserves to support the Egyptian pound and Egypt may seek a loan from the International Monetary Fund.
Source
: CIA
Company Name : AMOUN PHARMACEUTICALS CO SAE
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 1989
Commercial Registration Number : 1677, El Obour
Tax Card Number : 324-927-835
Issued Capital : £E 1,360,572,200
Paid up Capital : £E 1,360,572,200
Total Workforce : 2,800
Activities : Production of various chemicals.
Financial Condition : Good
Payments : Nothing detrimental uncovered
Operating Trend : Steady
AMOUN PHARMACEUTICALS CO SAE
Location : Block No.
51031
Street :
Cairo-Ismalia Road, Km-76
Area : 1st
First Industrial Zone, El Obour City
PO Box : 5
Town : Cairo
Country : Egypt
Telephone : (20-2) 46140000
/ 46149133 / 46140100 / 46101333
Facsimile : (20-2)
46140165 / 46140061 / 46140190
Mobile : (20-10)
6003000
Email : hr@amoun.com
Subject operates from a large suite of offices and a factory that are
owned and located in the Industrial Area of Cairo.
Branch Office (s)
Location Description
· El Saydla Building Office
premises
Smouha
Alexandria
Tel: (20-3)
4268132
· 24 Corniche El
Nile Street Office
premises
Assiut
Tel: (20-88)
2313135
· Amin Abou Zeid
Street Office
premises
Heliopolis
Cairo
Tel: (20-2)
46971807
Fax: (20-2)
46972822
· 10 Abeida Ibn El
Garah Office
premises
El Nozha
Heliopolis
Cairo
Name Position
· Dr Raed Shoukry
Ibrahim Chairman
·
Ashley John Dunster Director
·
Mohamed Salah Younes Director
·
Amardeep Singh Director
·
Anis Anton Aclimandos Director
·
Solis Nayer Director
· Hanan Kamal Human Resources Manager
· Michael Guirguis Finance Manager
· Dr Gehan Abd El Massih Tadros Production Manager
· Dr Hany Kamil Quality
Manager
· Mariam Wahaba Office
Manager
· Hany Ibrahim Marketing
Manager
· Dr Mervat Fayek Planning
Manager
· Sherif Samir IT
Manager
· Adel Darwish Engineering
Manager
· Mariam Wahaba Office
Manager
Date of
Establishment : 1989
Legal Form : Egyptian Joint
Stock Company
Commercial Reg.
No. : 1677, El Obour
Tax Card No. : 324-927-835
Authorised Capital : £E 2,000,000,000
Issued Capital : £E 1,360,572,200
Paid up Capital : £E 1,360,572,200
· Mercury Egypt
Pharmaceuticals 98.8%
· Egyptian businessmen
and private investors 1.2%
Activities: Engaged in the production of various chemicals, including amines, raw
materials for pharmaceuticals,
parapharmaceutical and veterinary preparations, as well as aerosol
bottles and containers.
Subject is ISO 9001, 14001 and 18001 accredited.
Import Countries: France, Germany, Belgium, United Kingdom and the
United States of America.
Export Countries: The United States of America, Romania, Russia, Kenya,
Ethiopia and 14 Arab States.
Brand Names: AMOUN
Operating Trend: Steady
Subject has a workforce of approximately 2,800 employees.
Financial highlights provided by local sources are given below:
Currency: Egyptian Pounds (£E)
Year Ending 31/12/10: Year Ending 31/12/11:
Total Sales £E
579,512,623 £E
585,169,314
Local sources consider subject’s financial condition to be Good.
The above financial figures are based on estimations by our local
sources.
·
Banque du Caire SAE
22 Adly Street
PO Box: 1495
Cairo
Tel: (20-2) 33904554
Fax: (20-2) 33908992
·
Misr International Bank (MIBANK)
14 Alfy Street
PO Box:
631
Cairo
Tel:
(20-2) 35931002
Fax:
(20-2) 35912306
·
National Bank of Egypt
24 Sherif Street
Cairo
Tel:
(20-2) 33924175
Fax:
(20-2) 33924143
·
Banque Misr
151 Mohamed Farid
Street
Cairo
Tel: (20-2)
33912711 / 33912106
Fax: (20-2)
33919779
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.33 |
|
|
1 |
Rs.89.05 |
|
Euro |
1 |
Rs.72.57 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.